Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial
by Loges, Sonja (Author)
, Heuser, Michael (Author)
, Chromik, Jörg (Author)
, Sutamtewagul, Grerk (Author)
, Kapp-Schwoerer, Silke (Author)
, Crugnola, Monica (Author)
, Di Renzo, Nicola (Author)
, Lemoli, Roberto (Author)
, Mattei, Daniele (Author)
, Fiedler, Walter (Author)
, Alvarado-Valero, Yesid (Author)
, Ben-Batalla, Isabel (Author)
, Waizenegger, Jonas (Author)
, Rieckmann, Lisa-Marie (Author)
, Janning, Melanie (Author)
, Collienne, Maike (Author)
, Imbusch, Charles (Author)
, Beumer, Niklas (Author)
, Micklem, David (Author)
, Nilsson, Linn H. (Author)
, Madeleine, Noëlly (Author)
, McCracken, Nigel (Author)
, Oliva, Cristina (Author)
, Gorcea-Carson, Claudia (Author)
, Gjertsen, Bjørn T. (Author)
,
Call Number:
Loading…
Located:
Loading…
Article (Journal)
Online Resource